Ameliorative effect of an oxovanadium (IV) complex against oxidative stress and nephrotoxicity induced by cisplatin

References

• Sooriyaarachchi M, White WM, Narendran A, et al. Chemoprotection by D-methionine against cisplatin-induced side-effects: insight from in vitro studies using human plasma. Metallomics. 2014;6(3):532–541. doi: 10.1039/C3MT00238A
   PubMed Web of Science ®Google Scholar
• Florea AM, Büsselberg D. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers. 2011;3(1):1351–1371. doi: 10.3390/cancers3011351
   PubMedGoogle Scholar
• Ulu R, Doğukan A, Tuzcu M, et al. Modulation of Nrf2/HO-1 by thymoquinone during cisplatin-induced nephrotoxicity. Turk Neph Dial Transpl. 2013;22(2):182–187. doi: 10.5262/tndt.2013.1002.09
   Google Scholar
• Camano S, Lazaro A, Moreno-Gordaliza E, et al. Cilastatin attenuates cisplatin-induced proximal tubular cell damage. J Pharmacol Exp Ther. 2010;334(2):419–429. doi: 10.1124/jpet.110.165779
   PubMed Web of Science ®Google Scholar
• Aleksunes LM, Goedken MJ, Rockwell CE, et al. Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity. J Pharmacol Exp Ther. 2010;335(1):2–12. doi: 10.1124/jpet.110.170084
   PubMed Web of Science ®Google Scholar
• Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 2008;73(9):994–1007. doi: 10.1038/sj.ki.5002786
   PubMed Web of Science ®Google Scholar
• Shelton LM, Park BK, Copple IM. Role of Nrf2 in protection against acute kidney injury. Kidney Int. 2013;84(6):1090–1095. doi: 10.1038/ki.2013.248
   PubMed Web of Science ®Google Scholar
• Ruiz S, Pergola PE, Zager RA, et al. Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int. 2013;83(6):1029–1041. doi: 10.1038/ki.2012.439
   PubMed Web of Science ®Google Scholar
• Bishayee A, Waghray A, Patel MA, et al. Vanadium in the detection, prevention and treatment of cancer: the in vivo evidence. Cancer Lett. 2010;294(1):1–12. doi: 10.1016/j.canlet.2010.01.030
   PubMed Web of Science ®Google Scholar
• Fedorova EV, Buryakina AV, Zakharov AV, et al. Design, synthesis and pharmacological evaluation of novel vanadium-containing complexes as antidiabetic agents. PLoS One. 2014;9(7):e100386. doi: 10.1371/journal.pone.0100386
   PubMed Web of Science ®Google Scholar
• Sankar Ray R, Roy S, Ghosh S, et al. Suppression of cell proliferation, DNA protein cross-links, and induction of apoptosis by vanadium in chemical rat mammary carcinogenesis. Biochim Biophys Acta. 2004;1675(13):165–173. doi: 10.1016/j.bbagen.2004.09.004
   PubMed Web of Science ®Google Scholar
• Kim AD, Zhang R, Kang KA, et al. Increased glutathione synthesis following Nrf2 activation by vanadyl sulfate in human change liver cells. Int J Mol Sci. 2011;12(12):8878–8894. doi: 10.3390/ijms12128878
   PubMed Web of Science ®Google Scholar
• Kim AD, Zhang R, Kang KA, et al. Jeju ground water containing vanadium enhances antioxidant systems in human liver cells. Biol Trace Elem Res. 2012;147(1–3):16–24. doi: 10.1007/s12011-011-9277-5
   PubMed Web of Science ®Google Scholar
• Sanna D, Ugone V, Micera G, et al. Temperature and solvent structure dependence of VO2+ complexes of pyridine-N-oxide derivatives and their interaction with human serum transferrin. Dalton Trans. 2012;41(24):7304–7318. doi: 10.1039/c2dt12503j
   PubMed Web of Science ®Google Scholar
• Sheela A, Sarada NC, Vijayaraghavan R. A possible correlation between antioxidant and antidiabetic potentials of oxovanadium (IV) complexes. Med Chem Res. 2013;22(6):2929–2937. doi: 10.1007/s00044-012-0287-4
   Web of Science ®Google Scholar
• Francik R, Krośniak M, Barlik M, et al. Impact of vanadium complexes treatment on the oxidative stress factors in Wistar rats plasma. Bioinorg Chem Appl. 2011;2011:206316. doi: 10.1155/2011/206316
   PubMed Web of Science ®Google Scholar
• Sakurai H, Hamada Y, Shimomura S, et al. Cysteine methyl ester-oxovanadium (IV) complex, preparation and characterization. Inorg Chim Acta. 1980;46:L119–L120. doi: 10.1016/S0020-1693(00)84158-4
   Web of Science ®Google Scholar
• Basu A, Bhattacharjee A, Samanta A, et al. Prevention of cyclophosphamide-induced hepatotoxicity and genotoxicity: effect of an L-cysteine based oxovanadium (IV) complex on oxidative stress and DNA damage. Environ Toxicol Pharmacol. 2015;40(3):747–757. doi: 10.1016/j.etap.2015.08.035
   PubMed Web of Science ®Google Scholar
• De S, Sen T, Chatterjee M. Reduction of oxidative stress by an ethanolic extract of leaves of Piper beetle (Paan) Linn. decreased methotrexate-induced toxicity. Mol Cell Biochem. 2015;409(1–2):191–197. doi: 10.1007/s11010-015-2524-x
   PubMed Web of Science ®Google Scholar
• Coşkun S, Gönül B, Ozer C, et al. The effects of dexfenfluramine administration on brain serotonin immunoreactivity and lipid peroxidation in mice. Cell Biol Toxicol. 2007;23(2):75–82. doi: 10.1007/s10565-006-0107-z
   PubMed Web of Science ®Google Scholar
• Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95(2):351–358. doi: 10.1016/0003-2697(79)90738-3
   PubMed Web of Science ®Google Scholar
• Rahman I, Kode A, Biswas SK. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat Protoc. 2006;1(6):3159–3165. doi: 10.1038/nprot.2006.378
   PubMed Web of Science ®Google Scholar
• McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 1969;244(22):6049–6055.
   PubMed Web of Science ®Google Scholar
• Luck HA. Spectrophotometric method for estimation of catalase. In: Bergmeyer HV, editor, Methods of enzymatic analysis. New York (NY): Academic Press; 1963. p. 886–888
   Google Scholar
• Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70(1):158–169.
   PubMed Web of Science ®Google Scholar
• Habig WH, Pabst MJ, Jakoby WB. Glutathione-S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem. 1974;249(22):7130–7139.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosenbrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265–276.
   PubMed Web of Science ®Google Scholar
• Ghosh P, Singha Roy S, Basu A, et al. Sensitization of cisplatin therapy by a naphthalimide based organoselenium compound through modulation of antioxidant enzymes and p53 mediated apoptosis. Free Radic Res. 2015;49(4):453–471. doi: 10.3109/10715762.2015.1012079
   PubMed Web of Science ®Google Scholar
• Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119(3):493–501. doi: 10.1083/jcb.119.3.493
   PubMed Web of Science ®Google Scholar
• Pitts AE, Van Loon JC, Beamish FE. The determination of platinum by atomic absorption spectroscopy: part I. Air-acetylene flames. Anal Chim Acta. 1970;50(2):181–194.
   Google Scholar
• Wang H, Jia Z, Sun J, et al. Nitrooleic acid protects against cisplatin nephropathy: role of COX-2/mPGES-1/PGE2 cascade. Mediators Inflamm. 2015;2015:293474.
   PubMed Web of Science ®Google Scholar
• Das B, Antoon R, Tsuchida R, et al. Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth. Neoplasia. 2008;10(10):1105–1119. doi: 10.1593/neo.08466
   PubMed Web of Science ®Google Scholar
• Ejitha S, Prathibha P, Indira M. Nrf2-mediated antioxidant response by ethanolic extract of Sida cordifolia provides protection against alcohol-induced oxidative stress in liver by upregulation of glutathione metabolism. Redox Rep. 2015;20(2):75–80. doi: 10.1179/1351000214Y.0000000108
   PubMed Web of Science ®Google Scholar
• Tan SM, de Haan JB. Combating oxidative stress in diabetic complications with Nrf2 activators: how much is too much? Redox Rep. 2014;19(3):107–117. doi: 10.1179/1351000214Y.0000000087
   PubMed Web of Science ®Google Scholar
• Basu A, Bhattacharjee A, Samanta A, Bhattacharya S. An oxovanadium(IV) complex protects murine bone marrow cells against cisplatin-induced myelotoxicity and DNA damage. Drug Chem Toxicol. Forthcoming. DOI:10.1080/01480545.2016.1237522.
   Web of Science ®Google Scholar